Kubota Pharmaceutical Holdings Co (TSE:4596) ROCE %: -71.35% (As of Mar. 2026)


TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
46 GF Score
Price 円56.00
GF Value 円39.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Kubota Pharmaceutical Holdings Co ROCE %?

Kubota Pharmaceutical Holdings Co TSE:4596 46 ROCE % is -71.35% as of Mar. 2026. GuruFocus rates TSE:4596 with a GF Score™ of 46/100 and a GF Value™ of 円39.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kubota Pharmaceutical Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2026 was -71.35%.

Kubota Pharmaceutical Holdings Co  (TSE:4596) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kubota Pharmaceutical Holdings Co ROCE % Related Terms

Kubota Pharmaceutical Holdings Co ROCE % Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co ROCE % Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -49.61 -48.01 -43.58 -64.27 -42.04

Kubota Pharmaceutical Holdings Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -78.94 -65.65 0.00 -71.35
TSE:4596
46GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co ROCE % Calculation

Kubota Pharmaceutical Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-675.381/( ( (1541.907 - 151.263) + (1979.457 - 157.373) )/ 2 )
=-675.381/( (1390.644+1822.084)/ 2 )
=-675.381/1606.364
=-42.04 %

Kubota Pharmaceutical Holdings Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1248.02/( ( (1979.457 - 157.373) + (1864.009 - 187.822) )/ 2 )
=-1248.02/( ( 1822.084 + 1676.187 )/ 2 )
=-1248.02/1749.1355
=-71.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -71.35% mean?
Kubota Pharmaceutical Holdings Co (TSE:4596) has a ROCE % of -71.35% as of Mar. 2026.
Is Kubota Pharmaceutical Holdings Co's ROCE % too high?
Kubota Pharmaceutical Holdings Co's current ROCE % is -71.35%. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's ROCE % compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's ROCE % of -71.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Kubota Pharmaceutical Holdings Co's current ROCE % is -71.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.87, compared to a current price of 円56.00 — trading 40.5% above its estimated fair value. The current ROCE % is -71.35%. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current ROCE % is -71.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円56.00 is trading 40.5% above its estimated GF Value™ of 円39.87. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • ROCE %: -71.35%
  • GF Value™: 円39.87 vs. price of 円56.00 (40.5% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
46GF Score

Get the complete analysis for TSE:4596

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円56.00
Price
円39.87
GF Value